Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Myelodysplastic Syndromes 30Leukemia, Myeloid, Acute 30Multiple Myeloma 24Lymphoma, Non-Hodgkin 24Hodgkin Disease 24Lymphoma 21Leukemia 21Graft vs Host Disease 21Leukemia, Lymphocytic, Chronic, B-Cell 20Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Myeloproliferative Disorders 15Lymphoma, Mantle-Cell 15Neoplasms 14Tuberous Sclerosis 13Lymphoma, Large B-Cell, Diffuse 13Hematologic Neoplasms 12Burkitt Lymphoma 12Primary Myelofibrosis 11Lymphoma, Follicular 11Breast Neoplasms 11Waldenstrom Macroglobulinemia 10Sarcoma 10Recurrence 10Neoplasms, Plasma Cell 10Neoplasm Metastasis 10Lymphoma, B-Cell, Marginal Zone 10Leukemia, Myelomonocytic, Chronic 10Prostatic Neoplasms 9Lymphangioleiomyomatosis 9

Interventions

Imatinib Mesylate 3Cryosurgery 3nirogacestat 2Blood Specimen Collection 2vactosertib 1strattice 1liposomal doxorubicin 1Toremifene 1Taxes 1Surveys and Questionnaires 1Sunitinib 1Sirolimus 1Saline Solution 1Radiofrequency Ablation 1Pregnancy 1Nivolumab 1Magnetic Resonance Spectroscopy 1Hydroxyurea 1High-Intensity Focused Ultrasound Ablation 1Embolization, Therapeutic 1Electrochemotherapy 1Doxorubicin 1Data Collection 1Cyclophosphamide 1Cryotherapy 1Bleomycin 1Biopsy 1Albumin-Bound Paclitaxel 1Abdominoplasty 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Desmoid Tumors × Sirolimus × Clear all
NCT01265030 2023-06-26

A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis

MaineHealth

Phase 1/2 Completed
9 enrolled 5 charts
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡